By recognizing and killing cancer cells, CD8+ T cells play a significant role in the anti-tumor immune response in patients with lung adenocarcinoma (Liu et al. 2023a, b; Song et al. 2022a, b; Sun et al. 2022). Here, CD8A is linked to cancer.